Catalyst Wire Dossier Catalyst Wire Dossier

BI 1005273

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI 1005273, covering 2014-10-16 to 2014-10-16. Get the full timeline:

Most recent: Clinical Trial Update: Single Rising Dose Study With Intravenous Infusion and Subcutaneous Injection of BI 1005273 in Healthy Male Volunteers. [Phase 1]

See pricing